Moonlake Immunotherapeutics Stock Probability of Future Stock Price Finishing Over 10.5
| MLTX Stock | USD 54.43 0.19 0.35% |
MoonLake |
MoonLake Immunotherapeuti Target Price Odds to finish over 10.5
The tendency of MoonLake Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 10.50 in 90 days |
| 54.43 | 90 days | 10.50 | close to 99 |
Based on a normal probability distribution, the odds of MoonLake Immunotherapeuti to stay above $ 10.50 in 90 days from now is close to 99 (This MoonLake Immunotherapeutics probability density function shows the probability of MoonLake Stock to fall within a particular range of prices over 90 days) . Probability of MoonLake Immunotherapeuti price to stay between $ 10.50 and its current price of $54.43 at the end of the 90-day period is over 95.1 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.07 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, MoonLake Immunotherapeuti will likely underperform. Additionally MoonLake Immunotherapeutics has an alpha of 0.0026, implying that it can generate a 0.002614 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). MoonLake Immunotherapeuti Price Density |
| Price |
Predictive Modules for MoonLake Immunotherapeuti
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MoonLake Immunotherapeuti. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MoonLake Immunotherapeuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MoonLake Immunotherapeuti Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MoonLake Immunotherapeuti is not an exception. The market had few large corrections towards the MoonLake Immunotherapeuti's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MoonLake Immunotherapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MoonLake Immunotherapeuti within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0 | |
β | Beta against Dow Jones | 2.07 | |
σ | Overall volatility | 2.77 | |
Ir | Information ratio | 0.04 |
MoonLake Immunotherapeuti Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MoonLake Immunotherapeuti for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MoonLake Immunotherapeuti can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MoonLake Immunotherapeuti had very high historical volatility over the last 90 days | |
| Net Loss for the year was (44.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| MoonLake Immunotherapeutics currently holds about 92.71 M in cash with (42.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.51. | |
| MoonLake Immunotherapeuti has a frail financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: MoonLake Immunotherapeutics Reports Q3 2024 Financial Results - MSN |
MoonLake Immunotherapeuti Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MoonLake Stock often depends not only on the future outlook of the current and potential MoonLake Immunotherapeuti's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MoonLake Immunotherapeuti's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 49.1 M | |
| Cash And Short Term Investments | 511 M |
MoonLake Immunotherapeuti Technical Analysis
MoonLake Immunotherapeuti's future price can be derived by breaking down and analyzing its technical indicators over time. MoonLake Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of MoonLake Immunotherapeutics. In general, you should focus on analyzing MoonLake Stock price patterns and their correlations with different microeconomic environments and drivers.
MoonLake Immunotherapeuti Predictive Forecast Models
MoonLake Immunotherapeuti's time-series forecasting models is one of many MoonLake Immunotherapeuti's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary MoonLake Immunotherapeuti's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about MoonLake Immunotherapeuti
Checking the ongoing alerts about MoonLake Immunotherapeuti for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for MoonLake Immunotherapeuti help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| MoonLake Immunotherapeuti had very high historical volatility over the last 90 days | |
| Net Loss for the year was (44.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| MoonLake Immunotherapeutics currently holds about 92.71 M in cash with (42.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.51. | |
| MoonLake Immunotherapeuti has a frail financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: MoonLake Immunotherapeutics Reports Q3 2024 Financial Results - MSN |
Additional Tools for MoonLake Stock Analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.